SHINE shares update on LEU-based method for Mo-99 production

01/21/2013 | Wisconsin State Journal (Madison)

SHINE Medical Technologies said the Los Alamos National Laboratory had succeeded in producing and separating molybdenum-99 from uranium sulfate solution. SHINE said the development shows the low-enriched uranium-based method can be used to produce the isotope on a commercial scale. The company is looking to meet at least 50% of the U.S. demand for the isotope by 2016.

View Full Article in:

Wisconsin State Journal (Madison)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD